DrBrainRx review
A single medication price per molecule, and a required monthly care fee that sits outside it.
The verdict
On the product pages, one month of semaglutide is $199 and one month of tirzepatide is $299. A required $25 monthly Care Access plan makes the real figures $224 and $324. The homepage's $129 and $249 are prepaid six-month rates.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 21
- From
- From $224/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 21 states
DrBrainRx sells both molecules by injection. Each figure covers a four-week vial. The stated dose ranges are 0.25 to 2.5 milligrams weekly and 2.5 to 15.
Who writes the prescription, and what do they see?
The Care Access plan is what the pages say the prescriber relationship costs. It buys dose titration and support, is stated as required, and is cancellable at any time. That is more detail about the clinical side than most sellers publish.
Two things are separated here that are usually blended. The medication has a price and the clinical support has its own. A reader can see what each costs, which is unusual, and must add them to get a monthly figure.
What happens when the dose goes up?
Each product page names its weekly dose range and sells one price. Neither page now says whether that price holds as the dose rises. A single listed price is not the same as a stated flat rate, so the dose question is not answered.
What the price includes
$199 plus the required $25 is $224 a month, and $299 plus $25 is $324. Six months paid monthly comes to $1,344 or $1,944. The homepage figures of $129 and $249 assume a six-month prepayment, $774 or $1,494 upfront, and exclude the plan fee. Each figure covers a four-week vial rather than a calendar month, so a heavy year would carry a thirteenth fill.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named on the pages.
Where it holds up, and where it does not
- Strength: Prescribing states named on the page
- Strength: Milligram ranges published for both
- Strength: The required fee is disclosed, not hidden
- Strength: Care Access is cancellable at any time
- Limitation: The headline omits a required $25
- Limitation: A four-week vial is not a calendar month
- Limitation: Prescribing limited to 21 states
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about DrBrainRx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader in one of the 21 prescribing states who will add the care fee to the headline.
- Wrong for
- A reader comparing headline figures without adding the required fee.
The evidence behind what DrBrainRx prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How DrBrainRx compares
| Seller | Who it suits | Go |
|---|---|---|
 EdgeRx | Readers who want a named compounding pharmacy and will check availability first | See EdgeRx → |
 DoctorAdam | A reader weighing a tablet against an injection who wants the decision to be about the routine rather than the cost. | See DoctorAdam → |
 Concierge MD LA | Readers who want one number covering care and medication and can commit four months | See Concierge MD LA → |
More GLP-1 telehealth sellers reviews: Believe HealthBetter U CareBetterMe RxBeyondMDBig Easy Weight LossBiltRx
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $199 the whole cost?
- No. A $25 monthly Care Access plan is stated as required, which makes the real figure $224 a month.
- Why does the homepage show $129 and $249?
- Those are per-month equivalents of the six-month prepaid bundles, $774 for semaglutide and $1,494 for tirzepatide. Bought a month at a time, the rates are $199 and $299.
- Does the price rise as my dose goes up?
- The pages do not say. Each lists one price beside a dose range of 0.25 to 2.5 milligrams on semaglutide and 2.5 to 15 on tirzepatide.
- What does the Care Access plan buy?
- Dose titration and support, per the product page. It is cancellable at any time, though the medication price assumes it is held.
- Is DrBrainRx legit?
- DrBrainRx is a GLP-1 telehealth sellers service. Its stated availability: 21 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is DrBrainRx expensive compared with other GLP-1 telehealth sellers?
- DrBrainRx publishes a starting figure of $224/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts DrBrainRx above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.